Home
Conditions
Hepatitis A

Clinical trial condition

Hepatitis A

Explore clinical trials studying Hepatitis A. Study availability and eligibility vary by location and protocol.

66 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Hepatitis A trial results

Completed

Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine

NCT00534885

Conditions: Digestive System Diseases, Enterovirus Infections, Hepatitis, +7 more
Locations: Changzhou City Center for Disease Control and Prevention Changzhou, Jiangsu, China

View Trial Details

Completed

Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico

NCT02112890

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +15 more
Locations: GSK Investigational Site Cuernavaca, Morelos, Mexico

View Trial Details

Completed

Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines

NCT01307436

Conditions: Digestive System Diseases, Enterovirus Infections, Hepatitis, +7 more
Locations: Beersheba, Israel

Petah Tikva, Israel

View Trial Details

Completed

Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)

NCT00326183

Conditions: Chickenpox, DNA Virus Infections, Digestive System Diseases, +25 more
Locations: Not specified

View Trial Details

Completed

Twinrix Pregnancy Registry

NCT03619590

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +15 more
Locations: Not specified

View Trial Details

Completed

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

NCT01037114

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

NCT01000324

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations: GSK Investigational Site Wilrijk, Belgium

View Trial Details

Completed

Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™

NCT00875485

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations: GSK Investigational Site Brussels, Belgium

GSK Investigational Site Hradec Králové, Czechia

View Trial Details

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

NCT00289744

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations: GSK Investigational Site Wilrijk, Belgium

View Trial Details

Completed

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

NCT00197184

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations: GSK Investigational Site North Adelaide, South Australia, Australia

GSK Investigational Site Carlton, Victoria, Australia

GSK Investigational Site Brussels, Belgium

GSK Investigational Site Barcelona, Spain

View Trial Details

Hepatitis A

Hepatitis A trial results

Related conditions